Both in Pharmaceuticals
Oncolytics Biotech vs Xilio Therapeutics
Over the past year ONCY returned −53.3% and XLO returned −18.0%; their daily moves had a correlation of 0.02.
ONCY −53.3% XLO −18.0%Growth of $1, one year, split-adjusted
| Metric | ONCY | XLO |
|---|---|---|
| Price | $0.5461 | $8.91 |
| Market cap | $71.6M | $58.6M |
| Today | +11.44% | −3.41% |
| 1 month | −30.0% | −1.4% |
| 6 months | −50.4% | +6.0% |
| Year to date | −37.5% | −0.6% |
| 1 year | −53.3% | −18.0% |
| Revenue growth (YoY) | — | +131.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $4.1M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.2% | 22.3% |
| Short % of float | 6.4% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).